{"meta":{"query_hash":"ca8eed8d22fc","filters":{"venue":"Human Gene Therapy Clinical Development"},"cohort_total":7,"direct_labels_cover":0,"predictions_cover":7,"exported":7,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ca8eed8d22fc","api":"https://metacan.xera.ac/api/v1/cohort?venue=Human+Gene+Therapy+Clinical+Development"},"results":[{"id":"W1920785403","doi":"10.1089/humc.2014.145","title":"A Multicenter, Single-Blind, Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of a Cell-Mediated Gene Therapy in Degenerative Knee Arthritis Patients","year":2015,"lang":"en","type":"article","venue":"Human Gene Therapy Clinical Development","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteoarthritis; WOMAC; Medicine; Cartilage; Adverse effect; Visual analogue scale; Clinical endpoint; Internal medicine; Randomized controlled trial; Arthritis; Surgery; Pathology","score_opus":0.19683239178574596,"score_gpt":0.416537915641443,"score_spread":0.21970552385569703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1920785403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911048,0.0015778848,0.00005165526,0.00028375257,0.00083305524,0.005995876,0.0000242358,0.000044501005,0.00008423011],"genre_scores_gemma":[0.9903979,0.0023517488,0.004520865,0.0014524823,0.00039901215,0.00034396158,0.0003212472,0.000063606676,0.00014920718],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99426556,0.0009968211,0.0026943653,0.00079900643,0.00073625264,0.00050800346],"domain_scores_gemma":[0.9973997,0.00059874146,0.00039476596,0.00053527433,0.0004366648,0.0006348672],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003252028,0.00045447279,0.0012082622,0.00017798805,0.00015872935,0.000037942078,0.00021492952,0.00028121963,0.00009326458],"category_scores_gemma":[0.00046674118,0.0003122914,0.00023351125,0.00028028787,0.00022675896,0.00006719208,0.00013168478,0.00038003674,0.00004995203],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3214864,0.023057703,0.01194458,0.0000076473125,0.000421278,0.00007114751,0.005310006,0.0000025238091,0.016575698,0.0000099540775,0.00022948744,0.6208836],"study_design_scores_gemma":[0.84812325,0.06844759,0.030042943,0.00018856363,0.00006863921,0.0000045411466,0.00014863358,0.000019088335,0.047122363,0.000040426665,0.005350797,0.00044313233],"about_ca_topic_score_codex":0.000010392419,"about_ca_topic_score_gemma":0.00008353279,"teacher_disagreement_score":0.6204404,"about_ca_system_score_codex":0.00013501261,"about_ca_system_score_gemma":0.0005676504,"threshold_uncertainty_score":0.99993294},"labels":[],"label_agreement":null},{"id":"W2323323362","doi":"10.1089/humc.2014.154","title":"Ferret and Pig Models of Cystic Fibrosis: Prospects and Promise for Gene Therapy","year":2015,"lang":"en","type":"review","venue":"Human Gene Therapy Clinical Development","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institutes of Health; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Genetic enhancement; Disease; Biology; Phenotype; Gene; Animal model; Gene delivery; Viral vector; Bioinformatics; Recombinant DNA; Computational biology; Cancer research; Medicine; Pathology; Genetics","score_opus":0.22756435923025517,"score_gpt":0.4447940573641431,"score_spread":0.21722969813388796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323323362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08016834,0.91555816,0.00017458676,0.000015916004,0.0001066914,0.0038223471,0.00009774675,0.000023091547,0.000033143402],"genre_scores_gemma":[0.0011377964,0.9899283,0.005820225,0.00011933088,0.00043406244,0.0011650387,0.00070157927,0.00018325374,0.0005104356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99552876,0.00050856324,0.0016567027,0.001287487,0.0004273945,0.0005910898],"domain_scores_gemma":[0.9976725,0.00012868429,0.0006078461,0.00085272494,0.00035281113,0.0003854496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002606164,0.0007555541,0.0020076009,0.00014775914,0.00019259572,0.000066251596,0.0005756857,0.00073068874,0.000017684277],"category_scores_gemma":[0.00006478535,0.0005944872,0.0003897862,0.0001361773,0.00036902705,0.000008335358,0.00027889851,0.0003171195,0.0000037851887],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029859224,0.0005725665,0.000022262684,0.0019309549,0.0012845515,0.000004567381,0.0001844235,0.0000037787865,0.006540893,0.00002166848,0.00055490073,0.9858935],"study_design_scores_gemma":[0.0076955105,0.015818842,0.000078885234,0.001481352,0.00017173892,0.000040280855,0.000013594752,0.000023812736,0.022143332,0.001342251,0.9497098,0.0014806467],"about_ca_topic_score_codex":0.0000028830348,"about_ca_topic_score_gemma":0.000013583161,"teacher_disagreement_score":0.98441285,"about_ca_system_score_codex":0.00006186926,"about_ca_system_score_gemma":0.0015606453,"threshold_uncertainty_score":0.99965066},"labels":[],"label_agreement":null},{"id":"W2420725116","doi":"10.1089/humc.2016.29012.kod","title":"Sequenom, the U.S. Supreme Court, and Personalized Medicine","year":2016,"lang":"en","type":"editorial","venue":"Human Gene Therapy Clinical Development","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dawson College","funders":"","keywords":"Supreme court; Personalized medicine; Law; Political science; Library science; Computer science; Bioinformatics; Biology","score_opus":0.10686721579517461,"score_gpt":0.42001869138472403,"score_spread":0.3131514755895494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420725116","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010061229,0.020615732,0.00043940032,0.07903447,0.8846262,0.0024327396,0.000057961777,0.0002419031,0.0024903584],"genre_scores_gemma":[0.0029932812,0.03478916,0.0008519542,0.0035648746,0.93768746,0.00009670007,0.0009231646,0.00013579344,0.018957637],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951843,0.00033691662,0.0015203813,0.00080132834,0.0017350724,0.0004220037],"domain_scores_gemma":[0.9963883,0.0016076136,0.00048119432,0.0006010859,0.00049207924,0.00042970246],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045726984,0.00048721477,0.001164154,0.00011154428,0.00042078254,0.000032897857,0.00033292512,0.0017105236,0.0013026531],"category_scores_gemma":[0.0004320685,0.00022422138,0.00020281965,0.00010730688,0.003805175,0.000025617157,0.00014458377,0.0015537018,0.000048440834],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046871987,0.00013806458,0.00008039393,0.000098531986,0.0006700399,0.000032621865,0.00081385457,9.670844e-9,0.00069526536,0.00045094627,0.92518044,0.0713711],"study_design_scores_gemma":[0.006939513,0.0006945298,0.005006795,0.0006742188,0.0001188297,0.000012491951,0.0000229334,0.000002179857,0.00006102375,0.002330111,0.98381275,0.00032464223],"about_ca_topic_score_codex":0.000022585959,"about_ca_topic_score_gemma":0.000018720988,"teacher_disagreement_score":0.07546959,"about_ca_system_score_codex":0.00017058958,"about_ca_system_score_gemma":0.0015615757,"threshold_uncertainty_score":0.9996103},"labels":[],"label_agreement":null},{"id":"W2562765584","doi":"10.1089/humc.2016.29019.per","title":"User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found","year":2016,"lang":"en","type":"editorial","venue":"Human Gene Therapy Clinical Development","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation, Science and Economic Development Canada","funders":"","keywords":"Key (lock); User Friendly; Genome editing; Computer science; Gene; Download; World Wide Web; Biology; Genetics; CRISPR; Operating system","score_opus":0.03171068162398359,"score_gpt":0.382900122455972,"score_spread":0.3511894408319884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562765584","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54863507,0.015927574,0.14845832,0.0040507885,0.27063692,0.010066086,0.0010340102,0.0005887034,0.000602545],"genre_scores_gemma":[0.008403012,0.0065811113,0.11530505,0.0018408368,0.84237117,0.0045936247,0.00338598,0.0006722341,0.016846964],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960621,0.00008743441,0.0012707295,0.0013849065,0.0004302309,0.00076461793],"domain_scores_gemma":[0.9972837,0.00050601695,0.00048757225,0.00096327515,0.00035952308,0.00039993826],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011356012,0.000672351,0.00071343937,0.00014297212,0.0007009961,0.00014937206,0.0009097509,0.0012587815,0.00006197363],"category_scores_gemma":[0.0011810762,0.00053706433,0.00023622836,0.00016034246,0.00018048013,0.000010142687,0.00068333047,0.0004314915,0.000028125165],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026059488,0.00008932573,0.00047069913,0.00007348707,0.00068495114,0.0000085154625,0.000095921445,0.000039463077,0.09187182,0.000028085484,0.854928,0.05144913],"study_design_scores_gemma":[0.001745852,0.00039089308,0.00070282834,0.00011995489,0.00006491048,0.000017246211,0.000032436536,0.0000051396773,0.09192748,0.00012423069,0.9042342,0.00063486124],"about_ca_topic_score_codex":0.000007070904,"about_ca_topic_score_gemma":0.00006627964,"teacher_disagreement_score":0.57173425,"about_ca_system_score_codex":0.00011177455,"about_ca_system_score_gemma":0.0005924644,"threshold_uncertainty_score":0.9997081},"labels":[],"label_agreement":null},{"id":"W2789451500","doi":"10.1089/humc.2017.249","title":"A Multicenter, Double-Blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of a Cell and Gene Therapy in Knee Osteoarthritis Patients","year":2018,"lang":"en","type":"article","venue":"Human Gene Therapy Clinical Development","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"WOMAC; Medicine; Osteoarthritis; Visual analogue scale; Placebo; Knee pain; Clinical trial; Internal medicine; Patella; Adverse effect; Urology; Physical therapy; Surgery; Pathology","score_opus":0.13105684447439805,"score_gpt":0.41690224746679483,"score_spread":0.2858454029923968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789451500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104595,0.0012182338,0.000016112039,0.00015100252,0.00067250227,0.0066993865,0.000010419726,0.000032686483,0.00015372371],"genre_scores_gemma":[0.99232435,0.0029551184,0.002459933,0.0011328075,0.000500508,0.00028541178,0.00008218037,0.000051253523,0.0002084076],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955544,0.00043841306,0.002256959,0.0007881821,0.0005037065,0.000458331],"domain_scores_gemma":[0.99808073,0.00041933826,0.00030199488,0.00052984554,0.0002650234,0.00040308593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025309674,0.00039012328,0.001026104,0.00014858125,0.00024003169,0.000037829377,0.00018034424,0.00024583624,0.00016067846],"category_scores_gemma":[0.00008264091,0.0002679455,0.00017552728,0.00018972422,0.00037698995,0.000059436217,0.00015604768,0.00031293696,0.000029943049],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40622142,0.005261789,0.007972418,0.00000719463,0.00014317206,0.000016613865,0.0018396269,4.5476334e-8,0.0041890433,0.00000960231,0.000023319597,0.5743157],"study_design_scores_gemma":[0.8477679,0.069492444,0.053566545,0.0001545984,0.000066625405,0.0000048011516,0.000057410936,0.0000029763971,0.023163913,0.000030262734,0.005393756,0.00029876333],"about_ca_topic_score_codex":0.000013235636,"about_ca_topic_score_gemma":0.00008929815,"teacher_disagreement_score":0.574017,"about_ca_system_score_codex":0.000049731567,"about_ca_system_score_gemma":0.0002459096,"threshold_uncertainty_score":0.9999773},"labels":[],"label_agreement":null},{"id":"W2963380471","doi":"10.1089/humc.2018.201","title":"The Landscape of Cellular and Gene Therapy Products: Authorization, Discontinuations, and Cost","year":2019,"lang":"en","type":"review","venue":"Human Gene Therapy Clinical Development","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Authorization; Cell therapy; Medicine; Genetic enhancement; Food and drug administration; Stem-cell therapy; Business; Pharmacology; Cell; Internal medicine; Gene; Biology; Computer science","score_opus":0.20598711153356525,"score_gpt":0.4292700288717852,"score_spread":0.22328291733821998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963380471","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020682532,0.9937776,0.0002857623,0.0010234237,0.00035498207,0.002398668,0.000009374616,0.000022811693,0.000059173213],"genre_scores_gemma":[0.00060055795,0.99532187,0.0010468903,0.00014145045,0.0004132342,0.000098437005,0.0006069952,0.000052070227,0.0017185066],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967697,0.00033365135,0.0016459442,0.0005723186,0.00045189253,0.00022647622],"domain_scores_gemma":[0.9980121,0.00040175117,0.0006868616,0.00047867012,0.0002640688,0.00015652466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025846674,0.0003390382,0.0013387533,0.00010463171,0.00029142064,0.00005144854,0.0001680851,0.0005146618,0.000041531337],"category_scores_gemma":[0.0000975053,0.00017968134,0.00015834472,0.00023562532,0.00068493694,0.000027723967,0.000085944295,0.00047994504,0.000007088845],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042795175,0.00015144375,0.00018043494,0.0011136603,0.00044093118,0.0000016707357,0.00021513796,3.0922525e-8,0.000085081505,0.00066784373,0.00027084767,0.9968301],"study_design_scores_gemma":[0.0015248321,0.0003354153,0.004867748,0.0015096024,0.00016921341,0.000011647102,0.000014945091,0.0000064669566,0.00012524436,0.00021594178,0.9909765,0.00024243954],"about_ca_topic_score_codex":0.0000022605475,"about_ca_topic_score_gemma":0.0000024916994,"teacher_disagreement_score":0.9965877,"about_ca_system_score_codex":0.000030003413,"about_ca_system_score_gemma":0.0009007491,"threshold_uncertainty_score":0.73271924},"labels":[],"label_agreement":null},{"id":"W4255681473","doi":"10.1089/hum.2014.154","title":"Ferret and Pig Models of Cystic Fibrosis: Prospects and Promise for Gene Therapy","year":2014,"lang":"en","type":"article","venue":"Human Gene Therapy Clinical Development","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health","keywords":"Cystic fibrosis; Genetic enhancement; Medicine; Gene; Biology; Internal medicine; Genetics","score_opus":0.06083135663043778,"score_gpt":0.3244637290561704,"score_spread":0.2636323724257326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255681473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98913133,0.0048864973,0.005062837,0.000066302084,0.00009170213,0.0006951574,0.000005019687,0.000010759577,0.000050369785],"genre_scores_gemma":[0.9761526,0.0046008537,0.01818911,0.00016920973,0.0003403589,0.00009986531,0.00005640699,0.0000328213,0.00035878594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854136,0.00007120114,0.0005034498,0.00057525904,0.00011087155,0.00019786469],"domain_scores_gemma":[0.9993108,0.00002266143,0.0001641257,0.0002816862,0.000120432196,0.00010031354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007122562,0.00018854043,0.00028061785,0.0000278505,0.00013759245,0.000021087879,0.000109784785,0.00015944634,0.000004260582],"category_scores_gemma":[0.0000316,0.00015114031,0.00006892658,0.00003151446,0.0001511122,0.0000035408962,0.000070960996,0.00005979673,5.502493e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008346123,0.0003002727,0.0022576326,0.00004235884,0.00016166932,2.5346353e-7,0.00023154073,0.000037655533,0.9477216,0.00021243001,0.00014257002,0.048057422],"study_design_scores_gemma":[0.0045385575,0.005083698,0.07578205,0.000034820347,0.00002106293,0.000011739756,0.00002118607,0.000370205,0.8846392,0.0039790682,0.025036504,0.0004818943],"about_ca_topic_score_codex":0.000002210459,"about_ca_topic_score_gemma":0.0000031758589,"teacher_disagreement_score":0.07352442,"about_ca_system_score_codex":0.0000059324207,"about_ca_system_score_gemma":0.00007405849,"threshold_uncertainty_score":0.6163323},"labels":[],"label_agreement":null}]}